BPCP.L Stock: BioPharma Credit PLC Stock Price, Analysis & Insights
Get live BPCP.L stock price $71.00, comprehensive BioPharma Credit PLC stock analysis, charts, news, and expert forecast. Real-time BPCP.L stock data and investment insights.
Loading chart data...
BioPharma Credit PLC (BPCP.L) Overview
BioPharma Credit PLC (BPCP.L) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, BPCP.L trades at $71.00 with a market capitalization of 812.43M . Over the past 52 weeks, BPCP.L has traded between $0.64 and $71.93 , with the current price positioned at approximately 99% of this range . The stock c...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 812.43M
- Current price: $71.00
- 52-week range: $0.64 - $71.93
- P/E ratio: 11.45
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from t...
Company Information
- CEO
- Pedro Gonzalez de Cosio
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Website
- https://www.bpcruk.com
- Address
- 51 New North Road
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 11.4)
✓ Lower volatility stock (Beta: 0.18) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BioPharma Credit PLC shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for BioPharma Credit PLC
- ⚠Investors should consider how BioPharma Credit PLC fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
812.43M
P/E Ratio (TTM)
11.45
Beta
0.18
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BPCP.L with peer companies:
- Price
- $123.50+2.07% (1D)
- Market cap
- 94.57B
- Price
- $1,420.00+2.75% (1D)
- Market cap
- 89.48B
- Price
- $622.50+0.08% (1D)
- Market cap
- 107.21B
- Price
- $463.00+1.31% (1D)
- Market cap
- 87.65B
- Price
- $165.20+3.25% (1D)
- Market cap
- 111.25B
- Price
- $1,466.00+1.10% (1D)
- Market cap
- 61.80B
- Price
- $867.00+1.76% (1D)
- Market cap
- 51.64B
- Price
- $298.00-1.49% (1D)
- Market cap
- 88.05B
- Price
- $544.00+0.74% (1D)
- Market cap
- 82.50B
- Price
- $97.40-0.61% (1D)
- Market cap
- 59.24B
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
71/100 ⭐⭐⭐⭐⭐
- Overall
- -0.0%
- NYSE
- -0.2%
- NASDAQ
- +0.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Technology | +0.8% | +1.1% | +3.0% | 52.1 | 77/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +0.3% | +2.0% | 28.0 | 76/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.0% | +0.9% | +1.5% | 19.8 | 71/100⭐⭐⭐⭐⭐ |
| Industrials | -0.1% | -0.8% | +2.9% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.5% | -1.0% | +0.7% | 22.0 | 53/100⭐⭐⭐ |
| Healthcare | -0.9% | -1.9% | +1.6% | 30.5 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.4% | +1.3% | -2.8% | 31.1 | 44/100⭐⭐⭐ |
| Energy | +0.9% | -3.2% | +0.3% | 36.1 | 34/100⭐⭐ |
| Real Estate | +0.1% | -1.5% | -0.5% | 50.0 | 30/100⭐⭐ |
| Utilities | +1.5% | -1.7% | -5.5% | 26.1 | 29/100⭐⭐ |
| Consumer Cyclical | -0.8% | -0.1% | -0.6% | 55.3 | 25/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.